Genetic Testing at AdventHealth Alerts Woman, Doctors to Aggressive Cancer Before it Develops
this is tagline
Samantha Arceneaux’s daughter was diagnosed with type 1 diabetes in 2021, which led to her and husband getting genetic testing to help better understand their daughter’s diagnosis. She had no idea this genetic test would not only change her life, but possibly save it. The test revealed she carries a genetic variant that virtually guarantees she will develop an aggressive form of thyroid cancer at some point in her life.
“As soon as something starts developing, they'll know to remove my thyroid while it's still very early and before it ever gets to stage 4,” Arceneaux told Florida Trend magazine. “It was definitely eye opening to know I have this cancer risk, because there was no family history.”
Arceneaux’s story is a good example of how genetic testing can be used for prevention and treatment of cancer.
“Probably in the next 10 to 15 years, it’ll become standard for all newborns,” said Dr. Wes Walker, director of genomics and personalized health at AdventHealth Central Florida Division, during a recent Florida Trend interview.
As a result of Samantha’s test, “We’re able to target that specific molecular abnormality with a specific medication,” Walker says. “It's treating it with a laser as opposed to a hammer, which can cause lots of collateral damage. The laser is much more precise.”
Learn more about Samantha’s story and other ways genetic testing is being used at AdventHealth.
12 items. To interact with these items, press Control-Option-Shift-Right Arrow. These items are in a slider. To advance slider forward, press Shift-Command-Right Arrow. To advance slider backward, press Shift-Command-Left Arrow.
News
AdventHealth Celebration Team Performs First-in-World Procedure Targeting Kidney Tumor with Sound Beams
Kidney-tumor patients have an innovative new treatment option, first performed recently by a surgical team at AdventHealth Celebration.
Podcast
Test Apple Podcast - All Episodes
Test Apple Podcast
Social Media Post
AdventHealthMD Social Media Post Test - Consumer Title
As the Official Healthcare Provider of the 2024 NASCAR Chicago Street Race, we’re thrilled to support such a memorable experience with this amazing community.
News
Clone of AdventHealth Celebration Team Performs First-in-world Procedure Targeting Kidney Tumor with Sound Beams
The innovative new treatment targets and destroys tumors using sound beams, noninvasively and without the need for needles and incisions.
Media Coverage
Consumer Title - AdventHealthMD Media Coverage Test
A summary of the article goes here. A summary of the article goes here. A summary of the article goes here. A summary of the article goes here.
News
AdventHealth Celebration Team Performs First-in-world Procedure Targeting Kidney Tumor with Sound Beams
The innovative new treatment targets and destroys tumors using sound beams, noninvasively and without the need for needles and incisions.
Video
Dr. Corbin on the gut microbiome research study
Dr. Corbin on the gut microbiome research study
News
AdventHealth Clinical Research Unit Recruiting Patients with Solid Tumors Harboring MTAP Deletion for Phase I Clinical Trial
Under the leadership of investigator Guru Sonpavde, MD, AdventHealth’s Clinical Research Unit (CRU), a collaborative between the AdventHealth Cancer Institute and AdventHealth Research Institute, is...
News
AdventHealth Research Institute conducting two studies on the impact of shift work on healthcare workers’ health
The AdventHealth Research Institute recently launched two new clinical studies to better understand and address the needs of healthcare employees who work night shifts.
News
AdventHealth Celebration Successfully Performs First Robotics-assisted Cochlear Implant Procedure in Florida with the iotaSOFT® Insertion System.
In January 2024, AdventHealth Celebration neurotologist Michael Seidman, MD, FACS, became the first in Florida and the Southeast to complete a robotics-assisted cochlear implant procedure using the...
News
New England Journal of Medicine highlights Guru Sonpavde, MD’s work in new immunotherapy-chemotherapy combination improving survival for patients with advanced urothelial carcinoma
The CheckMate 901 Phase III clinical trial results, recently published in the New England Journal of Medicine, found that combining the programmed death 1 (PD1) inhibitor immunotherapy nivolumab with...
News
Creed Guitarist Mark Tremonti and AdventHealth for Children Pediatrician Discuss the Southeast’s First Lifespan Down Syndrome Clinic
The new SMILE with Stella Tremonti Down Syndrome Clinic is the only lifespan program of its kind in the Southeast.